Last reviewed · How we verify
ACEI, SGLT-2i
ACEI, SGLT-2i is a Small molecule drug developed by Mansoura University. It is currently FDA-approved. Also known as: Captopril, forxiga.
ACE inhibitors and SGLT-2 inhibitors are used to treat conditions such as Diabetes Mellitus, Cardiovascular Diseases, and Heart Failure of Reduced Ejection Fraction (HFrEF). They are also studied in combination with other treatments, including beta blockers, for these conditions.
At a glance
| Generic name | ACEI, SGLT-2i |
|---|---|
| Also known as | Captopril, forxiga |
| Sponsor | Mansoura University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy (PHASE2, PHASE3)
- Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction
- PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy (NA)
- Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
- Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? (PHASE4)
- The STOP-MED CTRCD Trial (PHASE4)
- Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction (PHASE4)
- An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ACEI, SGLT-2i CI brief — competitive landscape report
- ACEI, SGLT-2i updates RSS · CI watch RSS
- Mansoura University portfolio CI
Frequently asked questions about ACEI, SGLT-2i
What is ACEI, SGLT-2i?
Who makes ACEI, SGLT-2i?
Is ACEI, SGLT-2i also known as anything else?
What development phase is ACEI, SGLT-2i in?
Related
- Manufacturer: Mansoura University — full pipeline
- Also known as: Captopril, forxiga
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing